We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us


Manufactures optical and digital equipment for the healthcare and consumer electronics sectors, including endoscopy a... read more Featured Products: More products

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
01 Mar 2023 - 03 Mar 2023

Osteopontin and Osteoprotegerin Investigated In Peripheral Artery Disease

By LabMedica International staff writers
Posted on 08 Sep 2022
Print article
mage: The AU560 automatic enzymatic analyzer (Photo courtesy of Sysmed Lab Europe)
mage: The AU560 automatic enzymatic analyzer (Photo courtesy of Sysmed Lab Europe)

Peripheral artery disease (PAD) is one of the many complications of systemic atherosclerosis and it is accompanied by high rates of cardiovascular diseases (CVD) morbidity and mortality. PAD is a common condition in which narrowed arteries reduce blood flow to the arms or legs.

Atherosclerosis is a complex procedure of different pathways. Among other cytokines, inflammation and calcification are known to be regulated also by well-known bone regulators, such as osteoprotegerin (OPG) and osteopontin (OPN). OPG is a secretory basic glycoprotein and a member of the tumor necrosis factor (TNF) receptor superfamily, acting as an inhibitor of bone resorption. OPN is a highly phosphorylated glycophosphoprotein having acidic characteristics and rich in aspartic acid.

Clinical Scientists at the Medical School University of Cyprus (Nicosia, Cyprus) and their colleagues enrolled 203 consecutive patients with symptomatic, established PAD requiring endovascular revascularization (percutaneous transluminal angioplasty–PTA and/or stent placement) of any or both of their lower limbs (PAD group–PADG). They also recruited 78 age- and sex-matched subjects with less than two classical cardiovascular risk factors (hypertension, diabetes, hyperlipidemia, smoking, family history of premature CAD) who served as control group (COG).

Overnight fasting, blood samples were obtained and glycemic and lipid parameters were immediately assayed in an AU560 automatic enzymatic analyzer (Olympus, Hamburg, Germany). The glycated hemoglobin (HbA1c) was determined by high-performance liquid chromatography (Menarini Diagnostics, Florence, Italy) only in diabetic patients. Serum OPN and OPG were assayed using quantikine immunoassay EIA kits (R&D Systems Inc., Minneapolis, MN, USA) and Metra, San Diego, CA, USA). The high-sensitivity C-Reactive Protein (hsCRP) levels were measured with latex-enhanced immunonephelometry (Dade Behring, Marburg, Germany).

The investigators reported that during 12-month follow-up, 82 major adverse cardiovascular events (MACE) were recorded (MACE subgroup). The rest of 124 PAD patients remained free of MACE (non-MACE subgroup). At baseline, OPG (9.89 ± 2.85 ng/mL versus 3.47 ± 1.95 ng/mL) and OPN (79.99 ± 38.29 ng/mL versus 35.21 ± 14.84 ng/mL) levels were significantly higher in PADG compared to COG, as well as in MACE subgroup compared to non-MACE subgroup (13.29 ± 3.23 ng/mL versus 10.86 ± 3 ng/mL and 96.45 ± 40.12 ng/mL versus 78.1 ± 38.29 ng/mL, respectively). An independent association of PAD with OPG and OPN was found in the whole patient cohort.

The authors concluded that baseline high OPG and OPN levels were independently associated with the presence of PAD. Even higher levels of those biomarkers were detected among PAD patients with MACE. The study was published on September 1, 2022 in the journal Cardiovascular Diabetology.

Related Links:
Medical School University of Cyprus
Menarini Diagnostics 
R&D Systems Inc 
Dade Behring 

Gold Supplier
Vaginosis Test
Rupture of Fetal Membranes Test
AmniSure ROM Test
Anti-Insulin ELISA Test
Flu A/B & RSV Multiplex RT PCR Test
Savvygen Flu A, Flu B & RSV

Print article



view channel
Image: Scientists have won USD 9.5 million to study emerging pathogens (Photo courtesy of Pexels)

Study of Emerging Pathogens to Better Understand Influenza-Antibody Interactions Could Improve Diagnostics

Outbreaks of Avian influenza have occurred around the world for over a century. The highly pathogenic H5N1 virus which was first identified in 1996 can lead to severe disease and has a high fatality rate... Read more


view channel
Image: Medical illustration of Carbapenem-resistant Enterobacteriacea (Photo courtesy of CDC, Stephanie Rossow)

Breakthrough Test Enables Targeted Antibiotic Therapy for Various Enterobacter Species

Bacteria of the Enterobacter genus are considered to be the most dangerous bacteria linked to hospital infections across the world. Some of their representatives demonstrate high resistance to commonly-used... Read more


view channel
Image: Flexible copper sensor made cheaply from ordinary materials (Photo courtesy of University of São Paulo)

Low-Cost Portable Sensor Detects Heavy Metals in Sweat

Heavy metals like lead and cadmium can be found in batteries, cosmetics, food and many other things that have become a part of daily life. However, they become toxic if they accumulate in the human body... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.